Denmark· DK-28104038806
Ceplene
A histamine dihydrochloride product containing histamindihydrochlorid, registered in Denmark by Laboratoires Delbert. The same ATC class is registered in 10 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Histamine dihydrochloride is registered in 10 of 19 countries.
Countries holding a registration under ATC L03AX14 (histamine dihydrochloride), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 6 of them publish a price we can compare per daily dose
Histamine dihydrochloride · ATC L03AX14
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- HISTAMINDIHYDROCHLORID
- Manufacturer
- Laboratoires Delbert
- Country
- Denmark (DK)
- ATC code
- L03AX14
- ATC class
- Histamine dihydrochloride
- Defined daily dose
- 0.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28104038806
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
42 interactions on record for histamine dihydrochloride.
Graded by severity as the source publishes them — 42 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Histamine dihydrochloride · interactions on record
42 records
- 42 moderate
Most severe, free to view
- DiphenhydraminA04AB05moderate
- CyproheptadinA15AA01moderate
- DiphenhydraminN01BX06moderate
- HydroxyzineN05BB01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L03AX14
Histamine dihydrochloride, as other registers publish it.
- FinlandCepleneLaboratoires Delbert x
- IcelandCepleneLaboratoires Delbert
- NorwayCepleneLaboratoires Delbert
- PolandCepleneLaboratoires Delbert
- CzechiaCEPLENELaboratoires Delbert, Paříž
- NetherlandsCeplene 0,5 mg/0,5 ml, oplossing voor injectieLaboratoires Delbert
- BelgiumCeplene 0.5 mg/0.5 mlNoventia Pharma
- IrelandCeplene 0.5 mg/0.5 ml solution for injectionLaboratoires DELBERT
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4e6815f6-a6eb-4d4f-b401-b5992df93a81 GET /v1/drugs/4e6815f6-a6eb-4d4f-b401-b5992df93a81?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektionsvæske, opløsning",
"source": "dkma",
"strength": "0,5 mg/ 0,5 ml",
"auth_role": "MOD",
"dk_drugid": "28104038806",
"substance": "HISTAMINDIHYDROCHLORID",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "39728"
}See everything about histamine dihydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.